Comparison of the Hemostatic Patch to Fibrin Sealant (TachoSil®) in Subjects Undergoing Hepatic Surgery

Exclusion Criteria

• •Subject will be undergoing a laparoscopic hepatic procedure where the Hemostatic Patch will be delivered and applied through a trocar
• •In subjects with documented history of cirrhosis, subject has uncorrected platelet count \<60,000 per mm³ as determined by laboratory tests performed immediately prior to surgery
• •Subject has severe coagulopathy defined as INR \> 2.0
• •Subject has Total Bilirubin \>2.5mg/dL
• •Subject has an active local infection at the Target Bleeding Site
• •Study procedure involves a liver transplant recipient